Searle Pakistan is an established pharmaceutical company with decades of experience in manufacturing, marketing and delivering quality healthcare solutions across Pakistan.
Under the management and strategic direction of IJARA Capital Partners, Searle is entering a renewed phase of growth focused on strengthening its core portfolio, expanding local manufacturing, introducing innovative and specialty products, and developing new international partnerships.
The company has built strong capabilities across multiple therapeutic areas and maintains relationships with leading global healthcare companies, including MSD, Organon, CSL Vifor and Santen.
With a strong pharmaceutical legacy and a forward-looking growth strategy, Searle Pakistan remains committed to improving access to quality healthcare and creating sustainable value for patients, partners and stakeholders.
Our commitment to excellence is demonstrated through following internationally recognized management, laboratory, environmental, and occupational health & safety standards:
Structured quality management and continual improvement.
Technically competent testing and reliable results.
Systematic management of environmental performance.
Internationally recognized occupational health & safety practices.